OHB is trading 4.83% down at β¬189.20 as of October 20, 2026, with no clearly reported company-specific announcement explaining the decline.
- Recent coverage focused on bullish analyst views and contract prospects, including IRISΒ², rather than news tied to this drop.
- European equities were under pressure, but available information does not establish that broader weakness caused OHBβs move.